RESUMEN
The effectiveness of radiotherapy in the treatment of malignant tumors in the head and neck, thorasic and upper abdominal regions is frequently limited by the tolerance of the spinal cord. Therefore knowledge of the factors that influence the tolerance of the spinal cord to radiation is of the upmost important. Safe limits for irradiation of the spinal cord determined in a number of clinical studies is on the conservative side from the point of view of tumor control probability. The bioeffect of a physical dose takes into account the treatment variables and the radiobiological characteristics of the relevant tissue; hence deciding spinal cord tolerance on the basis of bioeffect models would be better approach. The aim of the present study was to analyze the relationship of the prognostic factors with percentage incidence of spinal cord myelitis and to arrive at a spinal cord tolerance bioeffect dose TDF and ERD for optimum incidence of radiation myelitis.
Asunto(s)
Fraccionamiento de la Dosis de Radiación , Humanos , Incidencia , India/epidemiología , Mielitis/epidemiología , PronósticoRESUMEN
A prospective clinical and histopathological study of 103 patients with lymphomas is reported. Of these, 72 (69.9%) had non-Hodgkin's lymphoma (NHL) and 31 (30.1%) had Hodgkin's lymphoma (HL). The median age at presentation was 34 and 43 years for Hodgkin's and non-Hodgkin's lymphoma respectively, which is lower than that seen in the West. Fever and superficial lymphadenopathy were the commonest presenting features and 'B' symptoms were present in over 60% of both groups. Seventy-five per cent of NHL and 64.5% of HL presented in stages III and IV of the disease.